TRANSGENE BIOTEK
Smallcap | BSE
Sector
Here's the live share price of Transgene Biotek along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.94₹ 0.06
As on May 20, 2026, 04:01 PM IST
Source: Dion Global
Transgene Biotek Price Performance
Today's LowToday's High
₹3.01₹3.35
₹3.15
52 Weeks' Low52 Weeks' High
₹1.83₹5.26
₹3.15
Open Price
₹3.35
Prev. Close
₹3.09
Volume
28,328
Source: Dion Global
Transgene Biotek Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Transgene Biotek | -1.56 | 1.94 | 24.02 | -12.50 | -23.17 | -8.41 | -4.33 |
| Sun Pharmaceutical Industries | 3.07 | 12.74 | 9.05 | 5.77 | 10.14 | 26.15 | 22.32 |
| Divi's Laboratories | 1.88 | 10.17 | 9.98 | 7.06 | 7.27 | 28.44 | 11.35 |
| Torrent Pharmaceuticals | 3.81 | 6.46 | 5.22 | 19.94 | 37.48 | 38.74 | 26.75 |
| Cipla | 5.56 | 14.00 | 4.44 | -8.37 | -3.68 | 14.84 | 8.67 |
| Dr. Reddy's Laboratories | 4.34 | 7.12 | 3.10 | 5.80 | 7.74 | 13.99 | 4.74 |
| Mankind Pharma | 7.31 | 20.51 | 27.43 | 15.48 | 1.28 | 24.73 | 12.65 |
| Zydus Lifesciences | 10.86 | 11.17 | 15.53 | 12.22 | 17.92 | 27.15 | 11.10 |
| Lupin | 3.30 | -1.72 | 3.11 | 12.70 | 16.48 | 43.46 | 13.69 |
| Aurobindo Pharma | 1.37 | 11.00 | 30.90 | 25.63 | 27.39 | 36.05 | 8.16 |
| Laurus Labs | 6.00 | 20.14 | 33.13 | 37.48 | 128.74 | 63.26 | 23.02 |
| Biocon | 4.13 | 21.34 | 13.30 | 10.06 | 30.73 | 21.90 | 2.55 |
| Glenmark Pharmaceuticals | 4.30 | 6.57 | 16.27 | 26.28 | 65.38 | 57.76 | 31.38 |
| Alkem Laboratories | -0.16 | -3.34 | 1.00 | -4.49 | 3.53 | 18.72 | 12.73 |
| Abbott India | 0.84 | 7.47 | 4.67 | -6.97 | -10.72 | 8.76 | 11.42 |
| Anthem Biosciences | -4.00 | 7.42 | 14.21 | 20.01 | 6.44 | 2.10 | 1.26 |
| Ipca Laboratories | 9.04 | 11.91 | 13.33 | 14.37 | 13.17 | 34.02 | 8.27 |
| Ajanta Pharma | 2.15 | 14.75 | 8.60 | 26.93 | 22.77 | 34.42 | 19.76 |
| GlaxoSmithKline Pharmaceuticals | -2.46 | -3.47 | -9.71 | -6.42 | -15.78 | 21.81 | 9.96 |
| Gland Pharma | 20.14 | 23.50 | 21.69 | 21.97 | 48.12 | 35.36 | -6.88 |
Source: Dion Global
Over the last one year, Transgene Biotek has declined 23.17% compared to peers like Sun Pharmaceutical Industries (10.14%), Divi's Laboratories (7.27%), Torrent Pharmaceuticals (37.48%). From a 5 year perspective, Transgene Biotek has underperformed peers relative to Sun Pharmaceutical Industries (22.32%) and Divi's Laboratories (11.35%).
Transgene Biotek Financials
Source: Dion Global
Transgene Biotek Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 3.16 | 3.13 |
| 10 | 3.12 | 3.1 |
| 20 | 3.03 | 3.01 |
| 50 | 2.71 | 2.83 |
| 100 | 2.64 | 2.87 |
| 200 | 3.3 | 3.27 |
Source: Dion Global
Transgene Biotek Share Holding Pattern
In the latest quarter, Transgene Biotek remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 76.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Transgene Biotek Corporate Actions
Date Time | Announcement |
|---|---|
| May 15, 2026, 02:55 PM IST IST | Transgene Biotek - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company - This Is To Inform Yo |
| Apr 13, 2026, 11:37 PM IST IST | Transgene Biotek - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 13, 2026, 11:31 PM IST IST | Transgene Biotek - Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI Listing Obligations And Disclosure Requiremen |
| Apr 13, 2026, 11:29 PM IST IST | Transgene Biotek - Compliance-57 (4) : Prior intimation to the beginning of the quarter |
| Apr 13, 2026, 11:27 PM IST IST | Transgene Biotek - Compliance-57 (5) : intimation after the end of quarter |
Source: Dion Global
About Transgene Biotek
Transgene Biotek Ltd. is a Public Limited Listed company incorporated on 01/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1990PLC011065 and registration number is 011065. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 0.26 Cr. and Equity Capital is Rs. 75.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot Nos. 69 & 70, Sangareddy Dist. Telangana 502325
- Contact
Source: Dion Global
Management
- Dr. K Koteswara RaoChairman & Managing Director
- Mr. Santosh KumarDirector
- Mrs. Swetha MarriDirector
- Mrs. Sujana KadiamDirector
FAQs on Transgene Biotek Share Price
What is the share price of Transgene Biotek?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Transgene Biotek is ₹3.15 as on May 20, 2026.
What kind of stock is Transgene Biotek?
The Transgene Biotek is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Transgene Biotek?
The market cap of Transgene Biotek is ₹23.87 Cr as on May 20, 2026.
What are today's High and Low prices of Transgene Biotek?
Today’s highest and lowest price of Transgene Biotek are ₹3.35 and ₹3.01.
What are the 52 Week High and 52 Week Low of Transgene Biotek?
The 52-week high/low is the highest and lowest price at which Transgene Biotek stock has traded in the past 52-week or nearly a year. The 52-week high of Transgene Biotek is ₹5.26 and 52-week low of Transgene Biotek is ₹1.83 as on May 20, 2026.
How has the Transgene Biotek performed historically in terms of returns?
The Transgene Biotek has shown returns of 1.94% over the past day, 1.94% for the past month, 24.02% over 3 months, -23.17% over 1 year, -8.41% across 3 years, and -4.33% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Transgene Biotek?
P/E ratio of and PB ratio of Transgene Biotek are -12.55 and 2.70 on May 20, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕